Tomomi Kaneko

Lapatinib in Combination With Capecitabine Plus Oxaliplatin in Human Epidermal Growth Factor Receptor 2–Positive Advanced or Metastatic Gastric, Esophageal, or Gastroesophageal Adenocarcinoma: TRIO-013/LOGiC—A Randomized Phase III Trial

J. Randolph Hecht, Yung‐Jue Bang, Shukui Qin et al. · Journal of Clinical Oncology · 2015 · 621 citations · Full text

Medicine, Oncology, Pharmacology +16

MafB is required for islet β cell maturation

Isabella Artner, Bruno Blanchi, Jeffrey C. Raum et al. · Proceedings of the National Academy of Sciences · 2007 · 244 citations · Full text

Life Sciences, Developmental Biology, Endocrinology +16

Shared and distinct functions of RAGS and ELF‐1 in guiding retinal axons

Bruno Monschau, Claus Kremoser, Kunimasa Ohta et al. · The EMBO Journal · 1997 · 238 citations · Full text

Medicine, Neurobiology, Neuroscience +14

Lapatinib in combination with capecitabine plus oxaliplatin (CapeOx) in HER2-positive advanced or metastatic gastric, esophageal, or gastroesophageal adenocarcinoma (AC): The TRIO-013/LOGiC Trial.

J. Randolph Hecht, Yung‐Jue Bang, Shukui Qin et al. · Journal of Clinical Oncology · 2013 · 128 citations

Medicine, Oncology, Pharmacology +16

Involvement of the Polycomb-group gene<i>Ring1B</i>in the specification of the anterior-posterior axis in mice

Maki Suzuki, Yoko Mizutani-Koseki, Yu‐ichi Fujimura et al. · Development · 2002 · 97 citations

Life Sciences, Developmental Biology, Genetics +14